Epoetin

DRUG6 trials

Sponsors

Hoffmann-La Roche, General Hospital Sveti Duh, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Takeda, Nanfang Hospital, Southern Medical University

Conditions

AnemiaAsphyxiaChronic Kidney DiseaseEnd Stage Renal DiseaseEpoetinHematological MalignanciesLuspaterceptPoor Erythroid Engraftment

Phase 1

Erythropoietin for Infants With Brain Injuries Due to Oxygen Deprivation at Birth

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Asphyxia

Target: 15Updated: 2007-06-26

Phase 2

Luspatercept vs Epoetin in Treating Poor Erythroid Engraftment for Hematological Malignancies

Not yet recruitingNCT07636486

Nanfang Hospital, Southern Medical UniversityEpoetin, Hematological Malignancies, Luspatercept +1

Start: 2026-06-15End: 2030-12-31Target: 90Updated: 2026-06-09

Phase 3

A Study of Mircera for the Treatment of Anemia in Dialysis Patients

CompletedNCT00077597

Hoffmann-La RocheAnemia

Start: 2004-02-29End: 2006-06-30Updated: 2016-11-02

Comparison of Epoetin Alfa and Epoetin Omega in Anemic Dialysis Patients:Results of Efficacy Trial

CompletedNCT00322413

General Hospital Sveti DuhEnd Stage Renal Disease, Regular Dialysis Treatment, Renal Anemia

Start: 1997-01-31End: 1997-04-30Target: 80Updated: 2006-07-21

A Study of Intravenous Mircera for the Correction of Anemia in Dialysis Patients.

CompletedNCT00546481

Hoffmann-La RocheAnemia

Start: 2007-11-30End: 2009-12-31Updated: 2016-09-19

Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on Dialysis

CompletedNCT01478971

TakedaAnemia, Chronic Kidney Disease

Start: 2011-10-31End: 2013-02-28Updated: 2016-09-20

Related Papers

Correction of Anemia with Continuous Erythropoietin Receptor Activator in Korean Patients on Long-Term Hemodialysis

Journal of Korean Medical Science2014-01-017 citations